Press release
Migraine Treatment Market Outlook 2024: Exclusive Report By The Business Research Company
Migraine Treatment Market
The Business Research Company offers in-depth market insights through Migraine Treatment Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The migraine treatment market size has grown strongly in recent years. It will grow from $2.94 billion in 2023 to $3.22 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increased prevalence of migraines, increased healthcare expenditure, improved formulations of existing drugs, expansion of clinical research, development of novel therapies.
The migraine treatment market size is expected to see rapid growth in the next few years. It will grow to $4.78 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to growing awareness and education, emergence of monoclonal antibodies, increasing focus on pediatric migraines, expansion of non-pharmacological interventions, global initiatives for migraine research.. Major trends in the forecast period include advancements in therapeutic approaches, wearable devices and digital therapeutics, telemedicine and remote consultations, patient-centric care models, generic drug market growth, oral cgrp inhibitors..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=8126&type=smp
Market Segmentation:
The migraine treatment market covered in this report is segmented -
1) By Types: Episodic, Migraine With Aura, Chronic, Other Types
2) By Treatment: Acute/Abortive Treatment, Preventive/prophylactic Treatment, Non-Pharmacological Therapies and Devices
3) By End-User: Hospitals, Clinics, Homecare, Other End-users
Major Driver - Rising Global Migraine Prevalence Sparks Momentum In Migraine Treatment Market
The increasing prevalence of migraine is expected to propel the growth of the migraine treatment market. Migraine refers to a headache that occurs on one side of the brain only and causes severe pain or a pulsing sensation. Migraine treatment can stop future attacks and symptoms. For instance, in June 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, in 2021, 4.3% of persons over the age of 18 reported having a headache or migraine at least once every three months. Therefore, the increasing prevalence of migraine is driving the growth of the migraine treatment market .
Competitive Landscape:
Major companies operating in the migraine treatment market report are Pfizer Inc., Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG, Allergan plc, Abbott Laboratories, Allodynic Therapeutics LLC, AOBiome LLC, AstraZeneca plc, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Catalent Inc., Dr. Reddy's Laboratories Limited, Impel Pharmaceuticals Inc., AbbVie Inc., Alder BioPharmaceuticals Inc., Astellas Pharma Inc., Biohaven Pharmaceutical Holding Company Ltd., Bristol-Myers Squibb Company, CoLucid Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Endo International plc, Impax Laboratories Inc., Johnson & Johnson Inc., Lannett Company Inc., Lupin Limited, Merck & Co. Inc., Mylan N.V., Novo Nordisk A/S
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report
Top Trend - Revolutionizing Migraine Treatment Is Cutting-Edge Technological Innovations In The Market
Technological innovations are the key trend gaining popularity in the migraine treatment market. Major companies operating in the market are introducing technological innovations to sustain their position in the market. For instance, in March 2021, Neurolief, an Israel-based company that develops proprietary digital therapeutics neuromodulation technology, launched 'Brain Neuromodulation Technology,' used for migraine treatment. It is the first non-invasive neuromodulation system used to treat acute migraine at home.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Migraine Treatment Market Characteristics
3. Migraine Treatment Market Trends And Strategies
4. Migraine Treatment Market - Macro Economic Scenario
5. Migraine Treatment Market Size And Growth
…..
27. Migraine Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Migraine Treatment Market Outlook 2024: Exclusive Report By The Business Research Company here
News-ID: 3423050 • Views: …
More Releases from The Business research company
Fungal Protein Market 2024-2033: Trends, Analysis & Growth Forecast Outlook
The fungal protein market size has grown strongly in recent years. It will grow from $3.8 billion in 2023 to $4.06 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing demand for plant-based proteins, rising interest in alternative protein sources, rising allergies to animal proteins, expansion of food and beverage industry, environmental sustainability concerns,…
Flooring Contractors Market 2024-2033: Growth Trends, Forecast & Competitive Lan …
The flooring contractors market size has grown strongly in recent years. It will grow from $199.32 billion in 2023 to $216.05 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to housing and commercial construction trends, renovation and remodeling activities, design and aesthetics preferences, population growth and urbanization, commercial and retail sector expansion..
The flooring contractors market…
Feed Additives Market 2024-2033: Size, Share & Competitive Landscape Analysis
The feed additives market size has grown strongly in recent years. It will grow from $18.65 billion in 2023 to $20.05 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to livestock production growth, disease prevention, efficiency in feed conversion, nutritional requirements, rising meat consumption..
The feed additives market size is expected to see strong growth in…
End Stage Renal Disease (ESRD) Drug Market 2024-2033: Trends, Analysis & Growth …
The end stage renal disease (esrd) drug market size has grown rapidly in recent years. It will grow from $116.32 billion in 2023 to $132.86 billion in 2024 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to increasing incidence of end stage renal disease, growing aging population, improved access to healthcare services, government initiatives and policies, increasing adoption…
More Releases for Migraine
Digital Migraine Treatment Market: Size & Trends Shows a Rapid Growth by 2030- C …
A report was released recently that sheds lots of light on the Digital Migraine Treatment Industry. The report covers an overview of the Market along with a detailed explanation that provides a lot of insight. The report also analyzes the production as well as management technology in various end-user industries. An in-depth study in some new and prominent industry trends, analysis of the competition and regional analysis that is very…
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC /…
Migraine Therapeutics Pipeline Analysis -Results, Designation, Collaboration
Migraine is a type of a severe headache that is characterized by the intense throbbing in one area of the head. According to National Institute of Neurological Disorders and Stroke, migraine is three times common in women than in men and it is heralded by visual disturbances such as zig-zag lines vision and flashing lights.
Access Report Overview: https://www.psmarketresearch.com/market-analysis/migraine-therapeutics-pipeline-analysis
People having migraine generally have frequent attacks that cause, anxiety, stress,…
Migraine KOL Interview
ReportsWorldwide has announced the addition of a new report title Migraine KOL Interview to its growing collection of premium market research reports.
For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/biosimilar-insulin-market-access
February 08, 2017
We interviewed a neurologist based in the US who specializes in headache medicine to gauge his current and anticipated future use of acute and prophylactic agents in the treatment of episodic…
Migraine Disease Coverage Forecast and Market Analysis
ReportsWorldwide has announced the addition of a new report title Migraine Disease Coverage Forecast and Market Analysis to its growing collection of premium market research reports.
For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/migraine-disease-coverage-forecast-and-market-analysis
Introduction
Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range from hours to days.…
Global Anti-migraine Drugs Market to be Driven by Increasing Awareness Regarding …
A new market research study by Transparency Market Research provides a detailed analysis of the global market for anti-migraine drugs, including the major growth factors, barriers, product segmentation, current trends, major geographical segments, and competitive landscape. The research report, titled “Anti-Migraine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” also presents the historical statistics and forecast figures to the readers, with the help…
